Tandem Diabetes Care Inc

TD5A

Company Profile

  • Business description

    Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

  • Contact

    12400 High Bluff Drive
    San DiegoCA92130
    USA

    T: +1 858 366-6900

    E: [email protected]

    https://www.tandemdiabetes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    2,500

Stocks News & Analysis

stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.
stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,735.4083.10-0.94%
CAC 407,927.1525.40-0.32%
DAX 4024,163.55212.980.89%
Dow JONES (US)49,526.17537.29-1.07%
FTSE 10010,243.0647.690.47%
HKSE25,675.18287.55-1.11%
NASDAQ26,225.14410.08-1.54%
Nikkei 22560,815.95593.34-0.97%
NZX 50 Index12,762.92202.09-1.56%
S&P 5007,408.5092.74-1.24%
S&P/ASX 2008,505.3072.60-0.85%
SSE Composite Index4,131.533.86-0.09%

Market Movers